Insights on R&D innovation, emerging technologies, competitive strategy, and strategic decision-making.
For 30 years, salmon was the only PDRN source that mattered clinically. That assumption just broke. A December 2025 clinical...
PDRN has become one of the most watched ingredients in regenerative skincare and aesthetic medicine. For years, the competition was...
Two 2026 academic studies gave the cosmeceutical industry the proof it had been waiting on for years: PDRN can cross...
Skin microbiome research has grown from roughly 25 publications a year to a surge averaging 87.5 publications annually, with atopic...
DSM-Firmenich is moving beyond traditional fragrance masking and building a stronger platform around receptor-level sensory control, AI-assisted formulation, and next-generation...
The global commercial tire replacements for heavy-duty fleets exceed $22B annually, with abrasion-resistant tread life a critical determinant of total...
The global automotive seat cushion market was valued at $21.7B in 2023, growing at 6.5% CAGR, with premium segments dominated...
The global automotive laser headlamp market was valued at ~$1.1B in 2024, projected to reach ~$4B by 2028 as system...
L’Oréal’s latest cosmetics innovation activity points to a clear shift in beauty R&D: consumers want high-performance products, but they are...
For 30 years, salmon was the only PDRN source that mattered clinically. That assumption just broke. A December 2025 clinical study confirmed that low-molecular-weight peony...
PDRN has become one of the most watched ingredients in regenerative skincare and aesthetic medicine. For years, the competition was straightforward: who had the purest...
Two 2026 academic studies gave the cosmeceutical industry the proof it had been waiting on for years: PDRN can cross the stratum corneum. One study...
Over 90% of products marketed as “probiotic” cosmetics contain no live microorganisms. Instead, they deliver postbiotics lysates, ferments, metabolites without disclosing this substitution to consumers...
Around 12% of U.S. adults have used a GLP-1 drug such as semaglutide, tirzepatide, or a similar medication, and about 6% are using one today....
More than 35% of new skincare launches in 2024 used probiotics, prebiotics, or postbiotics. Barrier repair and hydration made up about 41% of microbiome cosmetic...
Over 40% of 2024 skincare launches featured microbiome-related ingredients. Yet approximately 90% of products labeled as “probiotic” actually contain postbiotics (ferments, lysates, filtrates) with no...
Cosmetic R&D teams are being asked to build skin microbiome portfolios while one core question remains unresolved: do barrier repair products need live bacteria, or...
An estimated 15 million U.S. adults currently use GLP-1 receptor agonist medications such as semaglutide and tirzepatide, with that figure projected to reach 30 million...
Precision fermentation is moving from early technical promise to commercial scale-up. GFI notes that fermentation-enabled protein production has expanded from a niche area into a...
Get a demo and explore how leading R&D teams use Slate to streamline discovery, stay ahead of competitors, and drive innovation.
